Short-term anti-remodeling effects of gliflozins in diabetic patients with heart failure and reduced ejection fraction: an explainable artificial intelligence approach

Introduction: Sodium-glucose cotransporter type 2 inhibitors (SGLT2i), gliflozins, play an emerging role for the treatment of heart failure with reduced left ventricular ejection fraction (HFrEF). Nevertheless, the effects of SGLT2i on ventricular remodeling and function have not been completely und...

Повний опис

Бібліографічні деталі

Автори:	Marco Mele, Paola Imbrici, Antonietta Mele, Maria Vittoria Togo, Giorgia Dinoi, Michele Correale, Natale Daniele Brunetti, Orazio Nicolotti, Annamaria De Luca, Cosimo Damiano Altomare, Antonella Liantonio, Nicola Amoroso
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Frontiers Media S.A. 2023-06-01
Серія:	Frontiers in Pharmacology
Предмети:	heart failure gliflozins sodium-glucose cotransporter 2 inhibitor explainable artificial intelligence machine learning
Онлайн доступ:	https://www.frontiersin.org/articles/10.3389/fphar.2023.1175606/full
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!